- Home
- ABUS vs OEC Comparison
ABUS vs OEC Comparison
Compare ABUS & OEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABUS
- OEC
- Stock Information
- Founded
- ABUS 2005
- OEC 1862
- Country
- ABUS United States
- OEC Luxembourg
- Employees
- ABUS N/A
- OEC N/A
- Industry
- ABUS Biotechnology: Pharmaceutical Preparations
- OEC Major Chemicals
- Sector
- ABUS Health Care
- OEC Industrials
- Exchange
- ABUS Nasdaq
- OEC Nasdaq
- Market Cap
- ABUS 711.2M
- OEC 592.4M
- IPO Year
- ABUS N/A
- OEC 2014
- Fundamental
- Price
- ABUS $4.20
- OEC $10.63
- Analyst Decision
- ABUS Strong Buy
- OEC Hold
- Analyst Count
- ABUS 3
- OEC 3
- Target Price
- ABUS $5.67
- OEC $11.33
- AVG Volume (30 Days)
- ABUS 1.0M
- OEC 604.9K
- Earning Date
- ABUS 11-05-2025
- OEC 11-06-2025
- Dividend Yield
- ABUS N/A
- OEC 0.78%
- EPS Growth
- ABUS N/A
- OEC N/A
- EPS
- ABUS N/A
- OEC 0.26
- Revenue
- ABUS $15,416,000.00
- OEC $1,841,700,000.00
- Revenue This Year
- ABUS $138.02
- OEC N/A
- Revenue Next Year
- ABUS N/A
- OEC $3.38
- P/E Ratio
- ABUS N/A
- OEC $40.28
- Revenue Growth
- ABUS 53.23
- OEC N/A
- 52 Week Low
- ABUS $2.71
- OEC $9.03
- 52 Week High
- ABUS $4.73
- OEC $19.48
- Technical
- Relative Strength Index (RSI)
- ABUS 84.85
- OEC 52.91
- Support Level
- ABUS $3.60
- OEC $9.90
- Resistance Level
- ABUS $4.10
- OEC $10.76
- Average True Range (ATR)
- ABUS 0.17
- OEC 0.34
- MACD
- ABUS 0.06
- OEC 0.03
- Stochastic Oscillator
- ABUS 83.33
- OEC 73.74
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.
About OEC Orion S.A.
Orion SA is a manufacturer of carbon black products. Carbon black is a powdered form of carbon used to create the desired physical, electrical and optical qualities of various materials. The company's operating segments are Specialty Carbon Black and Rubber Carbon Black. It generates maximum revenue from the Rubber Carbon Black segment. Rubber Carbon Black segment is used in the reinforcement of rubber in tires and mechanical rubber goods. The Specialty Carbon Black segment is used as pigments and performance additives in coatings, polymers, printing and special applications. Geographically, it derives a majority of its revenue from Germany.